Evidence map›Paper›PMID 35821762›Full record

ArticleHumanities & social sciences communications2022

COVID-19: a gray swan's impact on the adoption of novel medical technologies.

Denise R Dunlap, Roberto S Santos, Craig M Lilly, Sean Teebagy, Nathaniel S Hafer, Bryan O Buchholz, David D McManus

Open access · goldAbstract read
In one paragraph

Article in Humanities & social sciences communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 11 citations in OpenAlex.

  1. Point-of-care testing preferences 2020-2022: Trends over the years.Cardiovascular digital health journal · 2024
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Denise R DunlapUniversity of Massachusetts Lowell, Lowell, MA USA.ORCID 0000-0001-9832-2320
Roberto S SantosMerrimack College, North Andover, MA USA.
Craig M LillyUniversity of Massachusetts Chan Medical School, Worcester, MA USA.
Sean TeebagyUniversity of Massachusetts Chan Medical School, Worcester, MA USA.
Nathaniel S HaferUniversity of Massachusetts Chan Medical School, Worcester, MA USA.
Bryan O BuchholzUniversity of Massachusetts Lowell, Lowell, MA USA.
David D McManusUniversity of Massachusetts Chan Medical School, Worcester, MA USA.
University of Massachusetts Chan Medical School · USUniversity of Massachusetts Lowell · USMerrimack College · US

Funding

The Center for Advancing Point of Care in Heart, Lung, Blood and Sleep DiseasesU54HL143541 · NHLBI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI Nathaniel Scott Hafer · 2018 to 2026
$141.0M
University of Massachusetts Center for Clinical Science and Translational SupplementUL1TR001453 · NCATS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI LUZURIAGA, KATHERINE F · 2015 to 2024
$39.0M
NCATS NIH HHS UL1 TR001453NHLBI NIH HHS U54 HL143541
6 · The paper itself

Abstract

The COVID-19 pandemic offers a unique context and opportunity to investigate changes in healthcare professional perceptions towards the adoption of novel medical technologies, such as point-of-care technologies (POCTs). POCTs are a nascent technology that has experienced rapid growth as a result of COVID-19 due to their ability to increase healthcare accessibility via near-patient delivery, including at-home. We surveyed healthcare professionals before and during COVID-19 to explore whether the pandemic altered their perceptions about the usefulness of POCTs. Our network analysis method provided a structure for understanding this changing phenomenon. We uncovered that POCTs are not only useful for diagnosing COVID-19, but healthcare professionals also perceive them as increasingly important for diagnosing other diseases, such as cardiovascular, endocrine, respiratory, and metabolic diseases. Healthcare professionals also viewed POCTs as facilitating the humanization of epidemiology by improving disease management/monitoring and strengthening the clinician-patient relationship. As the accuracy and integration of these technologies into mainstream healthcare delivery improves, hurdles to their adoption dissipate, thereby encouraging healthcare professionals to rely upon them more frequently to diagnose, manage, and monitor diseases. The technological advances made in POCTs during COVID-19, combined with shifting positive perceptions of their utility by healthcare professionals, may better prepare us for the next pandemic.

Indexed as

Complex networksHealth humanities

Identifiers

PMID35821762
PMCPMC9263801
OpenAlexW4284881895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.